Literature DB >> 16143688

Important cutaneous manifestations of inflammatory bowel disease.

L B Trost1, J K McDonnell.   

Abstract

Inflammatory bowel disease (IBD) has many extraintestinal manifestations. Cutaneous manifestations are usually related to the activity of the bowel disease but may have an independent course. Anyone presenting with IBD should be examined for cutaneous manifestations. Pyoderma gangrenosum is a severe painful ulcerating disease that requires moist wound management and, in the absence of secondary infection, systemic corticosteroids, cyclosporine, or both. Infliximab may also be used. Erythema nodosum is a common cause of tender red nodules of the shins. Management includes leg elevation, NSAIDs, and potassium iodide. Oral manifestations of IBD include aphthous stomatitis, mucosal nodularity (cobblestoning), and pyostomatitis vegetans. Treatment should be directed both at the cutaneous lesions and at the underlying systemic condition.

Entities:  

Mesh:

Year:  2005        PMID: 16143688      PMCID: PMC1743347          DOI: 10.1136/pgmj.2004.031633

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  62 in total

1.  Cutaneous manifestations of inflammatory bowel disease.

Authors:  E Z Berkowitz; M Lebwohl
Journal:  J Eur Acad Dermatol Venereol       Date:  2000-09       Impact factor: 6.166

Review 2.  Aphthous ulcers: a difficult clinical entity.

Authors:  R G Shashy; M B Ridley
Journal:  Am J Otolaryngol       Date:  2000 Nov-Dec       Impact factor: 1.808

Review 3.  Underlying causes of erythema nodosum. Lesions may provide clue to systemic disease.

Authors:  R T Brodell; D Mehrabi
Journal:  Postgrad Med       Date:  2000-11       Impact factor: 3.840

Review 4.  Erythema nodosum: a clinical approach.

Authors:  M A González-Gay; C García-Porrúa; R M Pujol; C Salvarani
Journal:  Clin Exp Rheumatol       Date:  2001 Jul-Aug       Impact factor: 4.473

5.  Treatment of pyoderma gangrenosum with cyclosporin.

Authors:  J C Bijmer-Iest; S I Rompelman-Schiere; C J Van Ginkel
Journal:  Br J Dermatol       Date:  1991-09       Impact factor: 9.302

Review 6.  Management of aphthous ulcers.

Authors:  D R McBride
Journal:  Am Fam Physician       Date:  2000-07-01       Impact factor: 3.292

7.  Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.

Authors:  M H Tan; M Gordon; O Lebwohl; J George; M G Lebwohl
Journal:  Arch Dermatol       Date:  2001-07

Review 8.  Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions.

Authors:  M L Bennett; J M Jackson; J L Jorizzo; A B Fleischer; W L White; J P Callen
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

9.  Clinical features and treatment of peristomal pyoderma gangrenosum.

Authors:  A P Hughes; J M Jackson; J P Callen
Journal:  JAMA       Date:  2000-09-27       Impact factor: 56.272

10.  Peristomal dermatoses: a novel indication for topical steroid lotions.

Authors:  C C Lyon; A J Smith; C E Griffiths; M H Beck
Journal:  J Am Acad Dermatol       Date:  2000-10       Impact factor: 11.527

View more
  34 in total

Review 1.  Crohn's disease: a clinical update.

Authors:  Francis Ha; Hanan Khalil
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

2.  Oral Manifestations of Inflammatory Bowel Diseases: Two Case Reports.

Authors:  Manoela Seadi Pereira; Maria Cristina Munerato
Journal:  Clin Med Res       Date:  2016-02-10

Review 3.  Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis.

Authors:  C X W Tan; H S Brand; N K H de Boer; T Forouzanfar
Journal:  Br Dent J       Date:  2017-01-13       Impact factor: 1.626

Review 4.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 5.  Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.

Authors:  Paul E Evans; Darrell S Pardi
Journal:  MedGenMed       Date:  2007-03-19

6.  Clinical spectrum of vulva metastatic Crohn's disease.

Authors:  Susan Leu; Patricia K Sun; James Collyer; Aimee Smidt; Catherine S Stika; Bethanee Schlosser; Ginat W Mirowski; Arvydas Vanagunas; Alan L Buchman
Journal:  Dig Dis Sci       Date:  2009-05-07       Impact factor: 3.199

Review 7.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

8.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Jonathan S Levine; Robert Burakoff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

9.  Body image dissatisfaction in patients with inflammatory bowel disease.

Authors:  Sumona Saha; Ying-Qi Zhao; Samir A Shah; Silvia Degli Esposti; Sheldon Lidofsky; Jason Shapiro; Neal Leleiko; Renee Bright; Meaghan Law; Heather Moniz; Zahid Samad; Marjorie Merrick; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

Review 10.  Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?

Authors:  Fernando Tavarela Veloso
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.